Study Comparing Two Serums With Intense Pulsed Light for the Treatment of Moderate to Severe Photodamage and Crepiness on the Forearms

Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexFemale
Age50-80
SponsorGoldman, Butterwick, Fitzpatrick and Groff

About this trial

The primary objective is to compare Re-Q Pro-Longevity serum versus vehicle serum combined with Intense Pulsed Laser for the treatment of moderate to severe photodamage and crepiness on the dorsal forearms.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Female participants aged 50 to 80 years.

Fitzpatrick skin types I-IV.

Moderate to severe photodamage and crepiness on the arms, based on clinical evaluation, including fine wrinkling, coarse wrinkling, photodamage, and a global assessment as assessed with the 10-point Dermatologic Assessment Form and Photographic Scale

Willing and able to comply with all study requirements, including scheduled visits, treatment protocol, and follow-up assessments.

Disqualifiers

Patients with dark hair in the treatment area who are unwilling to shave the treated area prior to IPL treatments or who are unwilling to proceed knowing IPL will eliminate at least 50% of the hairs in the treatment area

A suntan in the treatment area or use of sunless tanner/spray-tan in the treatment areas 4 weeks prior to study treatment

Active infection, open wounds, or inflammatory dermatoses (e.g., eczema, psoriasis, dermatitis) in the treatment area.

Use of at-home energy-based devices intended for rejuvenation or fibroblastic/collagen stimulation on the treatment area within 30 days prior to treatment and during the study period.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Right Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy

    Drug

    Right Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy

  • Left Arm treated with vehicle serum and Intense Pulsed Light Therapy

    Drug

    Left Arm treated with vehicle serum and Intense Pulsed Light Therapy

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Group A Right Arm Treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light TherapyActive comparator 1 intervention
Group B: Group B Left Arm Treated with Vehicle serum and Intense Pulsed Light TherapySham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Physician Global Aesthetic Improvement Scale (PGAIS):

Physician assessed aesthetic improvement. All assessments will be made on 5-point scale (Circle One) 1. Very much improved 2. Much improved 3. Improved 4. No change 5. Worse

Time frame
Day 84 (Week 14 Post Second Treatment)

Secondary outcomes

1

Participant Global Aesthetic Improvement Scale (SGAIS):

Participant assessed aesthetic improvement. All assessments will be made on 5-point scale (Circle One) 1. Very much improved 2. Much improved 3. Improved 4. No change 5. Worse

Time frame
Day 84 (Week 14 Post Second Treatment)
2

10-point Dermatologic Assessment Form and Photographic Scale

Physician Assessed : (Circle One) Fine Wrinkling 0= Absent 1-2-3 = Mild 4-5-6 = Moderate 7-8-9 = Severe Coarse Wrinkling 0= Absent 1-2-3 = Mild 4-5-6 = Moderate 7-8-9 = Severe Abnormal Pigmentation 0= Absent 1-2-3 = Mild 4-5-6 = Moderate 7-8-9 = Severe Global 0= Absent 1-2-3 = Mild 4-5-6 = Moderate 7-8-9 = Severe

Time frame
Screening and Day 84 (Week 14 Post Second Treatment)
3

Skin Quality Assessment

Physician Assessed Skin Quality Assessment (SQS) Grading System (5-point scale) Circle One: Grade 0 - Excellent • Smooth, even skin • Firm and elastic • No visible crepiness or fine lines • Well-hydrated, healthy appearance Grade 1 - Good • Mild textural irregularity • Very subtle fine lines or early crepiness • Good firmness with minimal laxity • Overall youthful appearance Grade 2 - Fair • Noticeable texture changes • Early crepey appearance, especially with movement or pinching • Mild laxity or loss of elasticity • Skin may appear thinner or less hydrated Grade 3 - Poor • Obvious crepiness at rest • Moderate laxity • Fine lines clearly visible • Uneven surface texture and reduced resilience Grade 4 - Very Poor • Severe crepiness • Marked laxity and thinning • Prominent fine wrinkling • Dull, fragile, or atrophic appearance

Time frame
Screening and Day 84 (Week 14 Post Second Treatment)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: